| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |